Immage Biotherapeutics Corp.

IMMG · OTC
Analyze with AI
2/28/2017
11/30/2016
8/31/2016
5/31/2016
Operating Activities
Net Income-$0-$2-$0-$0
Dep. & Amort.$0$2$2$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$48-$0$0
Other Non-Cash-$72-$119-$70-$0
Operating Cash Flow-$72-$71-$69-$62
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$2$0$3
Financing Cash Flow-$2$2$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$73-$70-$69-$62
Supplemental Information
Beg. Cash$127$197$265$328
End Cash$54$127$197$265
Free Cash Flow-$72-$71-$69-$62